Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 29, Issue 11, Pages 739-742Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2018.04.007
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [HL09502, HL114570, HL128363, HL130167]
- American Heart Association [17GRNT33660671]
Ask authors/readers for more resources
Atherosclerosis is a chronic inflammatory and lipid-depository disease that eventually leads to acute cardiovascular events. Emerging evidence supports that epigenetic processes such as DNA methylation, histone modification, and noncoding RNAs play an important role in plaque progression and vulnerability, highlighting the therapeutic potential of epigenetic drugs in cardiovascular therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
